Pages that link to "Q53544508"
Jump to navigation
Jump to search
The following pages link to Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. (Q53544508):
Displaying 37 items.
- De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures (Q28277249) (← links)
- A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries. (Q30585618) (← links)
- FDR control with pseudo-gatekeeping based on a possibly data driven order of the hypotheses (Q30654623) (← links)
- Treatment outcome and patterns of failure in patients of pinealoblastoma: review of literature and clinical experience from a regional cancer centre in north India (Q30964830) (← links)
- MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system (Q33753435) (← links)
- DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis (Q34330397) (← links)
- Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas (Q34722504) (← links)
- Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma (Q35133413) (← links)
- Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group. (Q35224388) (← links)
- An interferon response gene expression signature is activated in a subset of medulloblastomas (Q36199866) (← links)
- Molecular markers in pediatric neuro-oncology (Q36344704) (← links)
- Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions (Q36451030) (← links)
- Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy (Q36544096) (← links)
- Molecular Diagnostics in Embryonal Brain Tumors (Q36619093) (← links)
- The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs). (Q36896072) (← links)
- The role of CD133+ cells in a recurrent embryonal tumor with abundant neuropil and true rosettes (ETANTR). (Q37402364) (← links)
- The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials (Q37564205) (← links)
- Histology and molecular pathology of pediatric brain tumors (Q37617838) (← links)
- The genetics of pediatric brain tumors (Q37738138) (← links)
- Evidence in medulloblastomas (Q37750058) (← links)
- Molecular diagnostics of CNS embryonal tumors (Q37794829) (← links)
- Pediatric brain tumors: a histologic and genetic update on commonly encountered entities (Q37797364) (← links)
- Treatment outcome and patterns of failure in patients of non-pineal supratentorial primitive neuroectodermal tumor: review of literature and clinical experience form a regional cancer center in north India. (Q38492284) (← links)
- miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN. (Q38973879) (← links)
- MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1. (Q39020346) (← links)
- Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors (Q41817349) (← links)
- Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types (Q41998084) (← links)
- H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications? (Q43553312) (← links)
- Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma (Q45750451) (← links)
- Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care. (Q47296254) (← links)
- CNS PNET molecular subgroups with distinct clinical features (Q48475821) (← links)
- Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor (Q48608885) (← links)
- Small Supratentorial, Extraaxial Primitive Neuroectodermal Tumor Causing Large Intracerebral Hematoma -Case Report- (Q50275597) (← links)
- Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish model of RB1 embryonal brain tumor, and are required for neural progenitor survival and proliferation. (Q55450522) (← links)
- Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis (Q57289629) (← links)
- Genomic aberrations in pediatric gliomas and embryonal tumors (Q84475591) (← links)
- Molecular Classification and Management of Rare Pediatric Embryonal Brain Tumors (Q89563571) (← links)